NCT03611868
CT.gov ↗
Phase 1b: APG-115+pembrolizumab
Unresectable or Metastatic Melanoma or Advanced Solid Tumors
pharma · Ph+ ALL · Unresectable or Metastatic Melanoma or Advanced Solid Tumors
Ascentage Pharma
Ascentage Pharma Group
Ascentage Pharma trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
USA HQ
2009 Founded
178 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- USA
- Founded
- 2009
- Employees
- 178
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Ascentage Pharma clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Ascentage Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Ascentage Pharma trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Ascentage Pharma.